David Lamond - Jun 8, 2022 Form 4 Insider Report for Cortexyme, Inc. (QNCX)

Role
Director
Signature
/s/ Caryn Gordon McDowell, as Attorney-in-Fact for David Lamond
Stock symbol
QNCX
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
4
Date filed
6/9/2022, 08:43 PM
Previous filing
Jun 3, 2022
Next filing
May 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QNCX Stock Option (right to buy) Award $0 +27K $0.00 27K Jun 8, 2022 Common Stock 27K $3.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares subject to the stock option shall vest in full on the one-year anniversary of the grant date of June 8, 2022.